{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:58:20Z","timestamp":1794362300641,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2314-B-006-074 -MY3"],"award-info":[{"award-number":["MOST 106-2314-B-006-074 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2326-B-006-004"],"award-info":[{"award-number":["MOST 110-2326-B-006-004"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW 110-TDU-B-212-124006"],"award-info":[{"award-number":["MOHW 110-TDU-B-212-124006"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone morphogenetic protein 2 (BMP2) is highly overexpressed in human non-small cell lung cancer (NSCLC) and correlates with tumor stage and metastatic burden. Although several lines of evidence suggest that BMP2 promotes cell migration and invasiveness in vitro, the in vivo role of BMP2 in the metastasis of lung adenocarcinoma cells remains less well understood. Here, we revealed that BMP2 is highly overexpressed in lung adenocarcinoma patients with lymph node metastasis compared with patients without lymph node metastasis. Using an in vivo orthotopic mouse model, we clearly demonstrated that BMP2 promotes lung adenocarcinoma metastasis. The depletion of BMP2 or its receptor BMPR2 significantly reduced cell migration and invasiveness. We further identified that BMP2\/BMPR2-mediated cell migration involves the activation of the SMAD1\/5\/8 signaling pathway, independent of the KRAS signaling pathway. Significantly, the depletion of SMAD1\/5\/8 or the inhibition of SMAD1\/5\/8 by LDN193189 inhibitor significantly reduced cell migration. These findings show that BMP2 promotes NSCLC metastasis, indicating that targeting the BMP2 signaling pathway may represent a potential therapeutic strategy for treating patients with metastatic NSCLC.<\/jats:p>","DOI":"10.1038\/s41598-022-20788-2","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:04:02Z","timestamp":1664460242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1\/5 activation"],"prefix":"10.1038","volume":"12","author":[{"given":"Cheng-Kuei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Ting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hungjiun","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"20788_CR1","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA 71, 7\u201333. https:\/\/doi.org\/10.3322\/caac.21654 (2021).","DOI":"10.3322\/caac.21654"},{"key":"20788_CR2","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","volume":"1","author":"C Gridelli","year":"2015","unstructured":"Gridelli, C. et al. Non-small-cell lung cancer. Nat. Rev. Dis. Primers 1, 15009. https:\/\/doi.org\/10.1038\/nrdp.2015.9 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"20788_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cellsig.2010.10.003","volume":"23","author":"B Bragdon","year":"2011","unstructured":"Bragdon, B. et al. Bone morphogenetic proteins: A critical review. Cell Signal 23, 609\u2013620. https:\/\/doi.org\/10.1016\/j.cellsig.2010.10.003 (2011).","journal-title":"Cell Signal"},{"key":"20788_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrc3500","volume":"13","author":"LM Wakefield","year":"2013","unstructured":"Wakefield, L. M. & Hill, C. S. Beyond TGF\u03b2: Roles of other TGF\u03b2 superfamily members in cancer. Nat. Rev. Cancer 13, 328\u2013341. https:\/\/doi.org\/10.1038\/nrc3500 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"20788_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cytogfr.2009.10.007","volume":"20","author":"C Sieber","year":"2009","unstructured":"Sieber, C., Kopf, J., Hiepen, C. & Knaus, P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 20, 343\u2013355. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.10.007 (2009).","journal-title":"Cytokine Growth Factor Rev."},{"key":"20788_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/383168a0","volume":"383","author":"Y Zhang","year":"1996","unstructured":"Zhang, Y., Feng, X., We, R. & Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383, 168\u2013172. https:\/\/doi.org\/10.1038\/383168a0 (1996).","journal-title":"Nature"},{"key":"20788_CR7","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1128\/mcb.14.9.5961","volume":"14","author":"BB Koenig","year":"1994","unstructured":"Koenig, B. B. et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell Biol. 14, 5961\u20135974. https:\/\/doi.org\/10.1128\/mcb.14.9.5961 (1994).","journal-title":"Mol. Cell Biol."},{"key":"20788_CR8","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.280.5366.1086","volume":"280","author":"JR Howe","year":"1998","unstructured":"Howe, J. R. et al. Mutations in the SMAD4\/DPC4 gene in juvenile polyposis. Science 280, 1086\u20131088. https:\/\/doi.org\/10.1126\/science.280.5366.1086 (1998).","journal-title":"Science"},{"key":"20788_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/88919","volume":"28","author":"JR Howe","year":"2001","unstructured":"Howe, J. R. et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28, 184\u2013187. https:\/\/doi.org\/10.1038\/88919 (2001).","journal-title":"Nat. Genet."},{"key":"20788_CR10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2012.06.035","volume":"150","author":"H Gao","year":"2012","unstructured":"Gao, H. et al. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 150, 764\u2013779. https:\/\/doi.org\/10.1016\/j.cell.2012.06.035 (2012).","journal-title":"Cell"},{"key":"20788_CR11","doi-asserted-by":"publisher","first-page":"21346","DOI":"10.1074\/jbc.M112.355834","volume":"287","author":"M Tarragona","year":"2012","unstructured":"Tarragona, M. et al. Identification of NOG as a specific breast cancer bone metastasis-supporting gene. J. Biol. Chem. 287, 21346\u201321355. https:\/\/doi.org\/10.1074\/jbc.M112.355834 (2012).","journal-title":"J. Biol. Chem."},{"key":"20788_CR12","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1084\/jem.20110840","volume":"208","author":"A Kobayashi","year":"2011","unstructured":"Kobayashi, A. et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J. Exp. Med. 208, 2641\u20132655. https:\/\/doi.org\/10.1084\/jem.20110840 (2011).","journal-title":"J. Exp. Med."},{"key":"20788_CR13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/carcin\/bgg100","volume":"24","author":"EM Langenfeld","year":"2003","unstructured":"Langenfeld, E. M. et al. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24, 1445\u20131454. https:\/\/doi.org\/10.1093\/carcin\/bgg100 (2003).","journal-title":"Carcinogenesis"},{"key":"20788_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1746-1596-9-123","volume":"9","author":"H Chu","year":"2014","unstructured":"Chu, H. et al. Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration. Diagn. Pathol. 9, 123. https:\/\/doi.org\/10.1186\/1746-1596-9-123 (2014).","journal-title":"Diagn. Pathol."},{"key":"20788_CR15","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.7314\/apjcp.2013.14.9.5293","volume":"14","author":"ZH Fei","year":"2013","unstructured":"Fei, Z. H., Yao, C. Y., Yang, X. L., Huang, X. E. & Ma, S. L. Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients. Asian Pac. J. Cancer Prev. 14, 5293\u20135299. https:\/\/doi.org\/10.7314\/apjcp.2013.14.9.5293 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"20788_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s12032-011-9852-9","volume":"29","author":"YJ Choi","year":"2012","unstructured":"Choi, Y. J. et al. The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients. Med. Oncol. 29, 582\u2013588. https:\/\/doi.org\/10.1007\/s12032-011-9852-9 (2012).","journal-title":"Med. Oncol."},{"key":"20788_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.lungcan.2009.02.020","volume":"66","author":"M Bieniasz","year":"2009","unstructured":"Bieniasz, M. et al. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer 66, 319\u2013326. https:\/\/doi.org\/10.1016\/j.lungcan.2009.02.020 (2009).","journal-title":"Lung Cancer"},{"key":"20788_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.athoracsur.2005.03.094","volume":"80","author":"EM Langenfeld","year":"2005","unstructured":"Langenfeld, E. M., Bojnowski, J., Perone, J. & Langenfeld, J. Expression of bone morphogenetic proteins in human lung carcinomas. Ann. Thorac. Surg. 80, 1028\u20131032. https:\/\/doi.org\/10.1016\/j.athoracsur.2005.03.094 (2005).","journal-title":"Ann. Thorac. Surg."},{"key":"20788_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.onc.1209110","volume":"25","author":"EM Langenfeld","year":"2006","unstructured":"Langenfeld, E. M., Kong, Y. & Langenfeld, J. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1\/5. Oncogene 25, 685\u2013692. https:\/\/doi.org\/10.1038\/sj.onc.1209110 (2006).","journal-title":"Oncogene"},{"key":"20788_CR20","doi-asserted-by":"publisher","first-page":"37335","DOI":"10.1074\/jbc.M111.256156","volume":"286","author":"YL Hsu","year":"2011","unstructured":"Hsu, Y. L. et al. Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2\/Snail signaling pathway. J. Biol. Chem. 286, 37335\u201337346. https:\/\/doi.org\/10.1074\/jbc.M111.256156 (2011).","journal-title":"J. Biol. Chem."},{"key":"20788_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1158\/0008-5472.448.65.2","volume":"65","author":"T Rothhammer","year":"2005","unstructured":"Rothhammer, T. et al. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 65, 448\u2013456 (2005).","journal-title":"Cancer Res."},{"key":"20788_CR22","first-page":"277","volume":"63","author":"F Pouliot","year":"2003","unstructured":"Pouliot, F., Blais, A. & Labrie, C. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res. 63, 277\u2013281 (2003).","journal-title":"Cancer Res."},{"key":"20788_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm733","volume":"8","author":"DG Beer","year":"2002","unstructured":"Beer, D. G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8, 816\u2013824. https:\/\/doi.org\/10.1038\/nm733 (2002).","journal-title":"Nat. Med."},{"key":"20788_CR24","doi-asserted-by":"publisher","first-page":"10768","DOI":"10.1111\/jcmm.15702","volume":"24","author":"F Huang","year":"2020","unstructured":"Huang, F. et al. BMP2 signalling activation enhances bone metastases of non-small cell lung cancer. J. Cell. Mol. Med. 24, 10768\u201310784. https:\/\/doi.org\/10.1111\/jcmm.15702 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"20788_CR25","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/onc.2008.232","volume":"27","author":"Y Katsuno","year":"2008","unstructured":"Katsuno, Y. et al. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27, 6322\u20136333. https:\/\/doi.org\/10.1038\/onc.2008.232 (2008).","journal-title":"Oncogene"},{"key":"20788_CR26","doi-asserted-by":"publisher","first-page":"17039","DOI":"10.1038\/cddiscovery.2017.39","volume":"3","author":"P Huang","year":"2017","unstructured":"Huang, P. et al. BMP-2 induces EMT and breast cancer stemness through Rb and CD44. Cell Death Discov. 3, 17039. https:\/\/doi.org\/10.1038\/cddiscovery.2017.39 (2017).","journal-title":"Cell Death Discov."},{"key":"20788_CR27","first-page":"2095","volume":"34","author":"A Fotinos","year":"2014","unstructured":"Fotinos, A. et al. Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells. Anticancer Res. 34, 2095\u20132104 (2014).","journal-title":"Anticancer Res."},{"key":"20788_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1165\/ajrcmb.17.3.2837","volume":"17","author":"YW Chu","year":"1997","unstructured":"Chu, Y. W. et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell. Mol. Biol. 17, 353\u2013360. https:\/\/doi.org\/10.1165\/ajrcmb.17.3.2837 (1997).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"20788_CR29","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1038\/sj.onc.1209464","volume":"25","author":"HH Yeh","year":"2006","unstructured":"Yeh, H. H., Lai, W. W., Chen, H. H., Liu, H. S. & Su, W. C. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 25, 4300\u20134309. https:\/\/doi.org\/10.1038\/sj.onc.1209464 (2006).","journal-title":"Oncogene"},{"key":"20788_CR30","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1038\/s41598-018-28566-9","volume":"8","author":"BS Tae","year":"2018","unstructured":"Tae, B. S. et al. Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis. Sci. Rep. 8, 10748. https:\/\/doi.org\/10.1038\/s41598-018-28566-9 (2018).","journal-title":"Sci. Rep."},{"key":"20788_CR31","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556-w560. https:\/\/doi.org\/10.1093\/nar\/gkz430 (2019).","journal-title":"Nucleic Acids Res."},{"key":"20788_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1759-7714.12046","volume":"5","author":"Q Chen","year":"2014","unstructured":"Chen, Q. et al. Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage. Thorac. Cancer 5, 14\u201324. https:\/\/doi.org\/10.1111\/1759-7714.12046 (2014).","journal-title":"Thorac. Cancer"},{"key":"20788_CR33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s12032-009-9358-x","volume":"27","author":"Y Park","year":"2010","unstructured":"Park, Y. et al. Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression. Med. Oncol. (Northwood, London, England) 27, 1192\u20131199. https:\/\/doi.org\/10.1007\/s12032-009-9358-x (2010).","journal-title":"Med. Oncol. (Northwood, London, England)"},{"key":"20788_CR34","doi-asserted-by":"publisher","first-page":"24443","DOI":"10.1074\/jbc.M502825200","volume":"280","author":"PB Yu","year":"2005","unstructured":"Yu, P. B., Beppu, H., Kawai, N., Li, E. & Bloch, K. D. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J. Biol. Chem. 280, 24443\u201324450. https:\/\/doi.org\/10.1074\/jbc.M502825200 (2005).","journal-title":"J. Biol. Chem."},{"key":"20788_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/ten.TEA.2010.0555","volume":"17","author":"JN Zara","year":"2011","unstructured":"Zara, J. N. et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng. Part A 17, 1389\u20131399. https:\/\/doi.org\/10.1089\/ten.TEA.2010.0555 (2011).","journal-title":"Tissue Eng. Part A"},{"key":"20788_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.spinee.2011.02.001","volume":"11","author":"KB Lee","year":"2011","unstructured":"Lee, K. B. et al. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation. Spine J. 11, 568\u2013576. https:\/\/doi.org\/10.1016\/j.spinee.2011.02.001 (2011).","journal-title":"Spine J."},{"key":"20788_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12920-015-0090-4","volume":"8","author":"M Rajski","year":"2015","unstructured":"Rajski, M., Saaf, A. & Buess, M. BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomas. BMC Med. Genom. 8, 16. https:\/\/doi.org\/10.1186\/s12920-015-0090-4 (2015).","journal-title":"BMC Med. Genom."},{"key":"20788_CR38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/annonc\/mdz011","volume":"30","author":"O Hamid","year":"2019","unstructured":"Hamid, O. et al. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann. Oncol. 30, 582\u2013588. https:\/\/doi.org\/10.1093\/annonc\/mdz011 (2019).","journal-title":"Ann. Oncol."},{"key":"20788_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature09677","volume":"470","author":"Z Ding","year":"2011","unstructured":"Ding, Z. et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470, 269\u2013273. https:\/\/doi.org\/10.1038\/nature09677 (2011).","journal-title":"Nature"},{"key":"20788_CR40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/cncr.23160","volume":"112","author":"LL Kodach","year":"2008","unstructured":"Kodach, L. L. et al. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer 112, 300\u2013306. https:\/\/doi.org\/10.1002\/cncr.23160 (2008).","journal-title":"Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20788-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20788-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20788-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:13:57Z","timestamp":1664460837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20788-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20788"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20788-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16310"}}